Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros











Intervalo de año de publicación
1.
Appl Microbiol Biotechnol ; 108(1): 306, 2024 Apr 24.
Artículo en Inglés | MEDLINE | ID: mdl-38656376

RESUMEN

The Streptomyces genus comprises Gram-positive bacteria known to produce over two-thirds of the antibiotics used in medical practice. The biosynthesis of these secondary metabolites is highly regulated and influenced by a range of nutrients present in the growth medium. In Streptomyces coelicolor, glucose inhibits the production of actinorhodin (ACT) and undecylprodigiosin (RED) by a process known as carbon catabolite repression (CCR). However, the mechanism mediated by this carbon source still needs to be understood. It has been observed that glucose alters the transcriptomic profile of this actinobacteria, modifying different transcriptional regulators, including some of the one- and two-component systems (TCSs). Under glucose repression, the expression of one of these TCSs SCO6162/SCO6163 was negatively affected. We aimed to study the role of this TCS on secondary metabolite formation to define its influence in this general regulatory process and likely establish its relationship with other transcriptional regulators affecting antibiotic biosynthesis in the Streptomyces genus. In this work, in silico predictions suggested that this TCS can regulate the production of the secondary metabolites ACT and RED by transcriptional regulation and protein-protein interactions of the transcriptional factors (TFs) with other TCSs. These predictions were supported by experimental procedures such as deletion and complementation of the TFs and qPCR experiments. Our results suggest that in the presence of glucose, the TCS SCO6162/SCO6163, named GarR/GarS, is an important negative regulator of the ACT and RED production in S. coelicolor. KEY POINTS: • GarR/GarS is a TCS with domains for signal transduction and response regulation • GarR/GarS is an essential negative regulator of the ACT and RED production • GarR/GarS putatively interacts with and regulates activators of ACT and RED.


Asunto(s)
Proteínas Bacterianas , Regulación Bacteriana de la Expresión Génica , Streptomyces coelicolor , Antraquinonas/metabolismo , Antibacterianos/biosíntesis , Antibacterianos/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Benzoisocromanquinonas , Represión Catabólica , Glucosa/metabolismo , Prodigiosina/análogos & derivados , Prodigiosina/biosíntesis , Prodigiosina/metabolismo , Metabolismo Secundario/genética , Streptomyces coelicolor/metabolismo , Streptomyces coelicolor/genética , Factores de Transcripción/genética , Factores de Transcripción/metabolismo
2.
Arch Microbiol ; 203(7): 4091-4100, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34052891

RESUMEN

This work aimed to investigate the production of prodigiosin by S. marcescens UCP 1549 in solid-state fermentation (SSF), as a sustainable alternative for reducing the production costs and environmental impact. Thus, different agro-industrial substrates were used in the formulation of the prodigiosin production medium, obtaining the maximum yield of pigment (119.8 g/kg dry substrate) in medium consisting of 5 g wheat bran, 5% waste soybean oil and saline solution. The pigment was confirmed as prodigiosin by the maximum absorbance peak at 535 nm, Rf 0.9 in TLC, and the functional groups by infrared spectrum (FTIR). Prodigiosin demonstrated stability at different values of temperature, pH and NaCl concentrations and antimicrobial properties, as well as not show any toxicity. These results confirm the applicability of SSF as a sustainable and promising technology and wheat bran as potential agrosubstrate to produce prodigiosin, making the bioprocess economic and competitive for industrial purposes.


Asunto(s)
Microbiología Industrial , Prodigiosina , Serratia marcescens , Antibacterianos/biosíntesis , Medios de Cultivo/química , Fermentación , Microbiología Industrial/métodos , Prodigiosina/biosíntesis , Serratia marcescens/metabolismo
3.
Electron. j. biotechnol ; Electron. j. biotechnol;40: 58-64, July. 2019. graf, tab, ilus
Artículo en Inglés | LILACS | ID: biblio-1053475

RESUMEN

Background: Prodigiosin has been demonstrated to be an important candidate in investigating anticancer drugs and in many other applications in recent years. However, industrial production of prodigiosin has not been achieved. In this study, we found a prodigiosin-producing strain, Serratia marcescens FZSF02, and its fermentation strategies were studied to achieve the maximum yield of prodigiosin. Results: When the culture medium consisted of 16.97 g/L of peanut powder, 16.02 g/L of beef extract, and 11.29 mL/L of olive oil, prodigiosin reached a yield of 13.622 ± 236 mg/L after culturing at 26 °C for 72 h. Furthermore, when 10 mL/L olive oil was added to the fermentation broth at the 24th hour of fermentation, the maximum prodigiosin production of 15,420.9 mg/L was obtained, which was 9.3-fold higher than the initial level before medium optimization. More than 60% of the prodigiosin produced with this optimized fermentation strategy was in the form of pigment pellets. To the best of our knowledge, this is the first report on this phenomenon of pigment pellet formation, which made it much easier to extract prodigiosin at low cost. Prodigiosin was then purified and identified by absorption spectroscopy, HPLC, and LCMS. Purified prodigiosin obtained in this study showed anticancer activity in separate experiments on several human cell cultures: A549, K562, HL60, HepG2, and HCT116. Conclusions: This is a promising strain for producing prodigiosin. The prodigiosin has potential in anticancer medicine studies.


Asunto(s)
Prodigiosina/biosíntesis , Prodigiosina/farmacología , Serratia marcescens/metabolismo , Antineoplásicos/farmacología , Arachis/química , Polvos , Prodigiosina/aislamiento & purificación , Espectrometría de Masas , Células Tumorales Cultivadas/efectos de los fármacos , Cromatografía Líquida de Alta Presión , Cromatografía Liquida , Técnicas de Cultivo de Célula , Fermentación , Aceite de Oliva/química , Acetatos , Nitrógeno
4.
Microb Cell Fact ; 17(1): 189, 2018 Nov 28.
Artículo en Inglés | MEDLINE | ID: mdl-30486842

RESUMEN

BACKGROUND: In Streptomyces, understanding the switch from primary to secondary metabolism is important for maximizing the production of secondary metabolites such as antibiotics, as well as for optimizing recombinant glycoprotein production. Differences in Streptomyces lividans bacterial aggregation as well as recombinant glycoprotein production and O-mannosylation have been reported due to modifications in the shake flask design. We hypothetized that such differences are related to the metabolic switch that occurs under oxygen-limiting conditions in the cultures. RESULTS: Shake flask design was found to affect undecylprodigiosin (RED, a marker of secondary metabolism) production; the RED yield was 12 and 385 times greater in conventional normal Erlenmeyer flasks (NF) than in baffled flasks (BF) and coiled flasks (CF), respectively. In addition, oxygen transfer rates (OTR) and carbon dioxide transfer rates were almost 15 times greater in cultures in CF and BF as compared with those in NF. Based on these data, we obtained respiration quotients (RQ) consistent with aerobic metabolism for CF and BF, but an RQ suggestive of anaerobic metabolism for NF. CONCLUSION: Although the metabolic switch is usually related to limitations in phosphate and nitrogen in Streptomyces sp., our results reveal that it can also be activated by low OTR, dramatically affecting recombinant glycoprotein production and O-mannosylation and increasing RED synthesis in the process.


Asunto(s)
Reactores Biológicos/microbiología , Oxígeno/farmacología , Recombinación Genética/genética , Streptomyces lividans/metabolismo , Cinética , Redes y Vías Metabólicas/efectos de los fármacos , Prodigiosina/análogos & derivados , Prodigiosina/biosíntesis , Prodigiosina/química , Espectroscopía Infrarroja por Transformada de Fourier , Streptomyces lividans/efectos de los fármacos , Streptomyces lividans/crecimiento & desarrollo
5.
Appl Biochem Biotechnol ; 180(6): 1152-1166, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27372741

RESUMEN

In the genus Streptomyces, carbon utilization is of significant importance for the expression of genes involved in morphological differentiation and antibiotic production. However, there is little information about the mechanism involved in these effects. In the present work, it was found that glucose exerted a suppressive effect on the Streptomyces coelicolor actinorhodin (Act) and undecylprodigiosin (Red) production, as well as in its morphological differentiation. Accordingly, using a high-density microarray approach in S. coelicolor grown under glucose repression, at early growth stages, a negative effect was exerted on the transcription of genes involved in Act and Red production, when compared with non-repressive conditions. Seven genes of Act and at least ten genes of Red production were down-regulated by glucose. Stronger repression was observed on the initial steps of antibiotics formation. On the contrary, the coelimycin P1 cluster was up-regulated by glucose. Regarding differentiation, no sporulation was observed in the presence of glucose and expression of a set of genes of the bld cascade was repressed as well as chaplins and rodlins genes. Finally, a series of transcriptional regulators involved in both processes were up- or down-regulated by glucose. This is the first global transcriptomic approach performed to understand the molecular basis of the glucose effect on the synthesis of secondary metabolism and differentiation in the genus Streptomyces. The results of this study are opening new avenues for further exploration.


Asunto(s)
Carbono/metabolismo , Metabolismo Secundario , Streptomyces coelicolor/citología , Streptomyces coelicolor/metabolismo , Antraquinonas/metabolismo , Antibacterianos/farmacología , Perfilación de la Expresión Génica , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Genes Bacterianos , Glucosa/farmacología , Prodigiosina/análogos & derivados , Prodigiosina/biosíntesis , Reacción en Cadena en Tiempo Real de la Polimerasa , Reproducibilidad de los Resultados , Metabolismo Secundario/efectos de los fármacos , Metabolismo Secundario/genética , Streptomyces coelicolor/efectos de los fármacos , Streptomyces coelicolor/genética
6.
Braz. j. phys. ther. (Impr.) ; 18(6): 538-543, 09/01/2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-732351

RESUMEN

BACKGROUND: The adapted arcometer has been validated for use in adults. However, its suitability for use in children can be questioned given the structural differences present in these populations. OBJECTIVE: To verify the concurrent validity, repeatability, and intra- and inter-reproducibility of the adapted arcometer for the measurement of the angles of thoracic kyphosis and lumbar lordosis in children. METHOD: Forty children were evaluated using both sagittal radiography of the spine and the adapted arcometer. The evaluations using the arcometer were carried out by two trained evaluators on two different days. In the statistical treatment, the intraclass correlation coefficient (ICC), Pearson's product moment correlation, Spearman's rho, the paired t test, and Wilcoxon's test were used (α=.05). RESULTS: A moderate and significant correlation was found between the x-ray and the adapted arcometer regarding thoracic kyphosis, but no correlation was found regarding lumbar lordosis. Repeatability and intra-evaluator reproducibility of the thoracic kyphosis and lumbar lordosis were confirmed, which was not the case of inter-evaluator reproducibility. CONCLUSION: The adapted arcometer can be used to accompany postural alterations in children made by the same evaluator, while its use for diagnostic purposes and continued evaluation by different evaluators cannot be recommended. Further studies with the aim of adapting this instrument for use in children are recommended. .


Asunto(s)
Proteínas Bacterianas/análisis , Glicoproteínas de Membrana/análisis , Glicoproteínas de Membrana/genética , Prodigiosina/biosíntesis , Serratia marcescens/metabolismo , Centrifugación por Gradiente de Densidad , Electroforesis en Gel de Poliacrilamida , Peso Molecular , Glicoproteínas de Membrana/biosíntesis , Solubilidad , Sarcosina/análogos & derivados , Serratia marcescens/análisis
7.
World J Microbiol Biotechnol ; 28(1): 145-53, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22806790

RESUMEN

The potential of three Serratia marcescens strains (CFFSUR-B2, CFFSUR-B3 and CFFSUR-B4) isolated from tropical regions in Mexico to inhibit the mycelial growth and conidial germination of Colletotrichum gloeosporioides, causal agent of fruit anthracnose, was evaluated. The ability of these strains to produce prodigiosin and chitinases when cultivated in oil seed-based media (peanut, sesame, soybean and castor bean) and in Luria-Bertani medium was determined. All of the strains exhibited similar fungal antagonistic activities and inhibited myceliar growth by more than 40% while inhibiting conidial germination by 81-89% (P = 0.01). The highest level of prodigiosin (40 µg/ml) was produced in the peanut-based medium while growth in soybean-based medium allowed the highest production of chitinases (56 units/ml), independent of the strain used. Strain CFFSUR-B2 grown in peanut medium was used to evaluate the effect of inoculum density and initial pH on metabolite production. The amount of prodigiosin produced increased with greater inoculum densities, with an initial density of 1 × 10(12) resulting in the highest production (60 µg/ml). Prodigiosin production was not affected by pH. The strains studied have the advantage of being adapted to tropical climates and are able to produce chitinases in the absence of chitin induction in vitro. These characteristics suggest their potential as biocontrol agents for fungal pathogens in tropical regions of the world.


Asunto(s)
Agentes de Control Biológico , Quitinasas/biosíntesis , Enfermedades de las Plantas/microbiología , Enfermedades de las Plantas/prevención & control , Prodigiosina/biosíntesis , Serratia marcescens/fisiología , Proteínas Bacterianas/biosíntesis , Secuencia de Bases , Carica/microbiología , Colletotrichum/patogenicidad , Medios de Cultivo , Girasa de ADN/genética , ADN Bacteriano/genética , Frutas/microbiología , Genes Bacterianos , Mangifera/microbiología , México , ARN Bacteriano/genética , ARN Ribosómico 16S/genética , Serratia marcescens/genética , Serratia marcescens/aislamiento & purificación , Clima Tropical
8.
Int J Mol Sci ; 13(2): 1284-1299, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22408391

RESUMEN

A series of selected 2-substituted imidazolines were synthesized in moderate to excellent yields by a modification of protocols reported in the literature. They were evaluated as potential non-classical bioisosteres of AHL with the aim of counteracting bacterial pathogenicity. Imidazolines 18a, 18e and 18f at various concentrations reduced the violacein production by Chromobacterium violaceum, suggesting an anti-quorum sensing profile against Gram-negative bacteria. Imidazoline 18b did not affect the production of violacein, but had a bacteriostatic effect at 100 µM and a bactericidal effect at 1 mM. Imidazoline 18a bearing a hexyl phenoxy moiety was the most active compound of the series, rendering a 72% inhibitory effect of quorum sensing at 100 µM. Imidazoline 18f bearing a phenyl nonamide substituent presented an inhibitory effect on quorum sensing at a very low concentration (1 nM), with a reduction percentage of 28%. This compound showed an irregular performance, decreasing inhibition at concentrations higher than 10 µM, until reaching 100 µM, at which concentration it increased the inhibitory effect with a 49% reduction percentage. When evaluated on Serratia marcescens, compound 18f inhibited the production of prodigiosin by 40% at 100 µM.


Asunto(s)
Acil-Butirolactonas , Chromobacterium/metabolismo , Percepción de Quorum/efectos de los fármacos , Serratia marcescens/metabolismo , Acil-Butirolactonas/síntesis química , Acil-Butirolactonas/química , Acil-Butirolactonas/farmacología , Indoles/metabolismo , Prodigiosina/biosíntesis
9.
Molecules ; 15(10): 6931-40, 2010 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-20938403

RESUMEN

A new strain of Serratia marcescens UCP1459 isolated from a semi-arid soil produced the natural red pigment prodigiosin, characterized by an uncommon pyrrolylpyrromethane skeleton. Prodigiosin is a promising drug due to its reported antifungal, immunosuppressive and anti-proliferative activities. The objective of this work was to indentify a suitable medium to simultaneously enhance S. marcescens growth and pigment production using renewable resources obtained from industrial wastes. S. marcescens produced the highest level of prodigiosin (49.5 g/L) at 48 h of cultivation using 6% "manipueira" (cassava wastewater) supplemented with mannitol (2%) at pH 7 and 28 °C. Carbohydrates in "manipueira" and mannitol play a role in the enhanced cell growth and prodigiosin production. The purified pigment extracted from the biomass was analyzed by mass spectrophotometry and showed the expected molecular weight of 324 Da corresponding to prodigiosin. In conclusion, we have successfully designed a new, economically feasible medium supporting enhanced S. marcescens growth and a high yield production of prodigiosin.


Asunto(s)
Antibacterianos/biosíntesis , Técnicas de Cultivo de Célula , Medios de Cultivo , Prodigiosina/biosíntesis , Serratia marcescens/metabolismo , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Técnicas de Cultivo de Célula/economía , Técnicas de Cultivo de Célula/métodos , Medios de Cultivo/química , Medios de Cultivo/economía , Residuos Industriales , Manihot , Manitol/metabolismo , Estructura Molecular , Prodigiosina/química , Prodigiosina/aislamiento & purificación , Administración de Residuos/métodos
10.
Oral Microbiol Immunol ; 21(1): 53-60, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16390342

RESUMEN

INTRODUCTION: Serratia marcescens is widely distributed in nature, and has emerged in the last years as an important nosocomial pathogen. The organism may also be found in subgingival biofilm in periodontitis patients. This study aimed to verify the subgingival prevalence of S. marcescens in different periodontal conditions and to evaluate whether the oral cavity would harbor strains similar to those causing infectious diseases. METHODS: The subgingival occurrence of S. marcescens was determined in 334 subjects. The phenotypic and genotypic diversity of 23 isolates from subgingival biofilm, 22 from extra-oral infections and 10 environmental strains, was compared by prodigiosin production, O and H serotyping and genotyping using polymorphic GC-rich repetitive sequences-polymerase chain reaction. RESULTS: S. marcescens was found more frequently in severe periodontitis patients (4.1%) than in gingivitis (3.2%) and healthy subjects (2.5%), but these differences were not statistically significant. Analysis of serotype distribution, prodigiosin production, and genotyping revealed that environmental strains were markedly different from most human isolates, either oral or extraoral. CONCLUSION: These data suggest that S. marcescens isolates from subgingival biofilm are not just contaminants from the environment, but that the oral cavity may act as a reservoir of strains able to promote human infections. However, further studies are needed to elucidate the role of this bacterium in the pathogenesis of periodontal diseases.


Asunto(s)
Biopelículas , Microbiología Ambiental , Encía/microbiología , Infecciones por Serratia/microbiología , Serratia marcescens/clasificación , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/análisis , Antígenos Bacterianos/análisis , Femenino , Secuencia Rica en GC/genética , Genotipo , Gingivitis/microbiología , Humanos , Masculino , Persona de Mediana Edad , Antígenos O/análisis , Periodontitis/microbiología , Prodigiosina/análisis , Prodigiosina/biosíntesis , Secuencias Repetitivas de Ácidos Nucleicos/genética , Serotipificación , Serratia marcescens/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA